Inside the Clinical Diagnostics Industry – Extract 6

Chapter 28 — Value Location Shifts Along the Diagnostic Chain

The following chapter extract is taken from Chapter 28 of Inside the Clinical Diagnostics Industry – Constraints Shaping Strategy – Towards Health Intelligence. It addresses structural shifts in value location.

---

In earlier phases of industrialisation, value concentrated in analytical performance.

Over time, determinants of value shifted downstream. Regulatory validation, reimbursement justification, interpretive frameworks, and governance mechanisms gained relative weight.

Analytical reliability remained necessary but insufficient for value realisation.

Value completion now occurs across multiple domains beyond the diagnostic product itself. Interpretation depends on clinical context. Adoption depends on reimbursement structures. Sustained utilisation depends on regulatory and evidence maintenance.

This relocation does not diminish technology. It expands the chain within which value is realised.

Strategy must therefore operate across the entire diagnostic chain rather than within the product boundary alone.

Value did not disappear. It relocated.